Quick Answer
Verastem, Inc. reported Total Revenue of $30.91 million for the year ending 2025.
- Verastem, Inc. showed an increase of +209.1% in Total Revenue from 2024 to 2025.
- This data is from Verastem, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2018 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $10.00 million | Q2 2018: $10.00 million | Q3 2018: $15.51 million | Q4 2018: $1.21 million | Q1 2019: $1.67 million | Q2 2019: $3.14 million | Q3 2019: $9.03 million | Q4 2019: $3.62 million | Q1 2020: $5.06 million | Q2 2020: $4.31 million | Q3 2020: $78.65 million | Q4 2020: $506.0 thousand | Q1 2021: $1.01 million | Q2 2021: $500.0 thousand | Q3 2021: $2.0 thousand | Q1 2022: $2.60 million | Q2 2024: $10.00 million | Q2 2024: $10.00 million | Q2 2025: $2.14 million | Q3 2025: $11.24 million.
- Over the full 10 years of available data (2018 to 2025), Verastem, Inc.'s Total Revenue has grown by 15.7%.
- Historical annual values: Fiscal year 2025: $30.91 million | Fiscal year 2024: $10.00 million | Fiscal year 2024: $10.00 million | Fiscal year 2022: $2.60 million | Fiscal year 2022: $2.60 million | Fiscal year 2021: $2.05 million | Fiscal year 2021: $2.05 million | Fiscal year 2020: $88.52 million | Fiscal year 2019: $17.46 million | Fiscal year 2018: $26.72 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: